Dr. Josiah Rich, Co-Director

Dr. Josiah Rich, M.D.
Co-Director, The Center for Prisoner Health and Human Rights

Josiah D. Rich, MD, MPH is a Professor of Medicine and Community Health at Brown Medical School and Attending Physician at The Miriam Hospital. He has expertise in the overlap between infectious diseases and addiction. He has published over 90 peer-reviewed publications and has federal funding for research, prevention and care for substance-using populations. A consultant on the American International Health Alliance funded by Providence-Togliatti, Sumara, Russia exchange project. He is the Director and co-founder of The Center for Prisoner Health and Human Rights at The Miriam Hospital Immunology Center.

Contact Jody Rich

Selected Publications:

    1. Zaller, N., P. Thurmond, and J.D. Rich, Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners. Public Health Rep, 2007. 122(1): p. 49-54.

    2. Zaller, N., et al., Routine HIV testing in US prisons. Lancet Infect Dis, 2007. 7(7): p. 440-1.

    3. Tedeschi, S.K., et al., Vaccination in juvenile correctional facilities: state practices, hepatitis B, and the impact on anticipated sexually transmitted infection vaccines. Public Health Rep, 2007. 122(1): p. 44-8.

    4. Schwartz, R.P., M. McKenzie, and J.D. Rich, Opioid addiction and incarceration: an overview. Med Health R I, 2007. 90(5): p. 157-8.

    5. Rich, J.D., et al., Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend, 2007. 89(2-3): p. 292-7.

    6. Rich, J.D., Health Issues in Prisons and Jails. J Urban Health, 2007.

    7. McKenzie, M. and J.D. Rich, Heroin in the corrections system: introduction. Med Health R I, 2007. 90(5): p. 140-1.

    8. Beletsky, L., et al., Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health, 2007. 84(1): p. 126-36.

    9. Beckwith, C.G., et al., HIV testing experiences among male and female inmates in Rhode Island. AIDS Read, 2007. 17(9): p. 459-64.

    10. Beckwith, C.G., et al., Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS, 2007. 21(1): p. 41-7.

    11. Allen, S.A. and J.D. Rich, Prisons and mental health. N Engl J Med, 2007. 356(2): p. 197-8.

    12. Zaller, N.D., et al., Linkage to methadone treatment from acute opiate detoxification treatment. J Opioid Manag, 2006. 2(6): p. 341-6.

    13. Vallabhaneni, S., et al., Prisoners favour hepatitis C testing and treatment. Epidemiol Infect, 2006. 134(2): p. 243-8.

    14. Rich, J.D., J.A. Mitty, and C.G. Beckwith, Editorial comment: correctional opportunities to address the HIV/AIDS epidemic. AIDS Read, 2006. 16(5): p. 258.

    15. Rich, J.D., et al., Specialized STD care in Rhode Island. Med Health R I, 2006. 89(6): p. 212.

    16. Rich, J.D., et al., Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users. Epidemiol Infect, 2006. 134(3): p. 478-84.

    17. Merchant, R.C., et al., Demographic, geographic, and temporal patterns of ambulance runs for suspected opiate overdose in Rhode Island, 1997-20021. Subst Use Misuse, 2006. 41(9): p. 1209-26.

    18. Hammer, S.M., et al., Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA, 2006. 296(7): p. 827-43.

    19. Hammer, S.M., et al., Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. Top HIV Med, 2006. 14(3): p. 827-43.

    20. Beckwith, C.G., et al., A success story: HIV prevention for injection drug users in Rhode Island. Subst Abuse Treat Prev Policy, 2006. 1: p. 34.

    21. Allen, S.A., et al., Deaths of detainees in the custody of US forces in Iraq and Afghanistan from 2002 to 2005. MedGenMed, 2006. 8(4): p. 46.

    22. Zaller, N., et al., The overlapping epidemics of viral hepatitis/HIV, addiction and incarceration: the situation in Rhode Island. Med Health R I, 2005. 88(12): p. 424-7.

    23. Taylor, L.E., et al., Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report. AIDS Read, 2005. 15(11): p. 629-31, 634-6, 638.

    24. Spaete, J.P. and J.D. Rich, HIV prevention and care in incarcerated populations. Focus, 2005. 20(8): p. 1-5.

    25. Rich, J.D., et al., Linkage with methadone treatment upon release from incarceration: a promising opportunity. J Addict Dis, 2005. 24(3): p. 49-59.

    26. Rich, J.D., et al., Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health, 2005. 82(3): p. 411-9.

    27. McKenzie, M., et al., Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program. J Opioid Manag, 2005. 1(3): p. 147-51.

    28. Macalino, G.E., et al., Community incidence of hepatitis B and C among reincarcerated women. Clin Infect Dis, 2005. 41(7): p. 998-1002.

    29. Macalino, G.E., D. Dhawan, and J.D. Rich, A missed opportunity: hepatitis C screening of prisoners. Am J Public Health, 2005. 95(10): p. 1739-40.

    30. Henry, P.C. and J.D. Rich, Editorial comment: the complexities of homelessness and HIV. AIDS Read, 2005. 15(11): p. 613.

    31. Edlin, B.R., et al., Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis, 2005. 40 Suppl 5: p. S276-85.

    32. Boutwell, A.E. and J.D. Rich, Arrested, addicted: heroin users in the Rhode Island Corrections System. Med Health R I, 2005. 88(12): p. 421-3.

    33. Boutwell, A.E., S.A. Allen, and J.D. Rich, Opportunities to address the hepatitis C epidemic in the correctional setting. Clin Infect Dis, 2005. 40 Suppl 5: p. S367-72.

    34. Yeni, P.G., et al., Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA, 2004. 292(2): p. 251-65.

    35. Vallabhaneni, S., et al., Prisoners' attitudes toward Hepatitis B vaccination. Prev Med, 2004. 38(6): p. 828-33.

    36. Taylor, L.E., J.D. Rich, and K.T. Tashima, Peginterferon plus ribavirin for hepatitis C in HIV-infected patients. N Engl J Med, 2004. 351(22): p. 2340-2; author reply 2340-2.

    37. Stozek, M.A., et al., Prescribing syringes to injection drug users with HIV: an important clinical and public health tool. J Assoc Nurses AIDS Care, 2004. 15(2): p. 59-63.

    38. Rompalo, A.M., et al., Evaluation of possible effects of continued drug use on HIV progression among women. Int J STD AIDS, 2004. 15(5): p. 322-7.

    39. Rich, J.D., L.E. Taylor, and S.A. Allen, Screening for hepatitis C virus infection in adults. Ann Intern Med, 2004. 141(7): p. 575-6; author reply 576.

    40. Rich, J.D., et al., A syringe prescription program to prevent infectious disease and improve health of injection drug users. J Urban Health, 2004. 81(1): p. 122-34.

    41. Macalino, G.E., et al., Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health, 2004. 94(7): p. 1218-23.

    42. Kwara, A., et al., Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients. AIDS Patient Care STDS, 2004. 18(6): p. 341-7.

    43. Boutwell, A. and J.D. Rich, Syringe access for injection drug users in Rhode Island. Med Health R I, 2004. 87(1): p. 15-6.

    44. Boutwell, A. and J.D. Rich, HIV infection behind bars. Clin Infect Dis, 2004. 38(12): p. 1761-3.

    45. Allen, S.A., et al., Confined treatment continued. Gastroenterology, 2004. 126(3): p. 928.

    46. Taylor, L.E., et al., Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey. J Addict Dis, 2003. 22(1): p. 67-78.

    47. Stancliff, S., et al., Syringe access for the prevention of blood borne infections among injection drug users. BMC Public Health, 2003. 3: p. 37.

    48. Rich, J.D., et al., Prescribing syringes to injection drug users: what the family physician should know. Am Fam Physician, 2003. 68(1): p. 45-7.

    49. Rich, J.D., et al., A review of the case for hepatitis B vaccination of high-risk adults. Am J Med, 2003. 114(4): p. 316-8.

    50. Macalino, G.E., et al., Drug use patterns over time among HIV-seropositive and HIV-seronegative women: the HER study experience. J Acquir Immune Defic Syndr, 2003. 33(4): p. 500-5.

    51. Clarke, J., et al., Hepatitis B vaccination of incarcerated women: a pilot program. J Health Care Poor Underserved, 2003. 14(3): p. 318-23.

    52. Allen, S.A., et al., Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med, 2003. 138(3): p. 187-90.

    53. Yeni, P.G., et al., Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA, 2002. 288(2): p. 222-35.

    54. Rich, J.D., F.A. Wolf, and G. Macalino, Strategies to improve access to sterile syringes for injection drug users. AIDS Read, 2002. 12(12): p. 527-35.

    55. Rich, J.D., et al., Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc (Wash), 2002. 42(6 Suppl 2): p. S58-61.

    56. Rich, J.D., et al., HIV seroprevalence of adult males incarcerated for a sexual offense in Rhode Island, 1994-1999. JAMA, 2002. 288(2): p. 164-5.

    57. Howard, A.A., et al., A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 2002. 16(16): p. 2175-82.

    58. Desai, A.A., et al., The importance of routine HIV testing in the incarcerated population: the Rhode Island experience. AIDS Educ Prev, 2002. 14(5 Suppl B): p. 45-52.

    59. Thomas, D.L., et al., Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis, 2001. 183(6): p. 973-6.

    60. Rich, J.D., et al., Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island. Subst Use Misuse, 2001. 36(5): p. 535-50.

    61. Rich, J.D., et al., The genesis of syringe prescription to prevent HIV in Rhode Island. Health Matrix Clevel, 2001. 11(1): p. 129-45.

    62. Rich, J.D., et al., Syringe prescription to prevent HIV infection in Rhode Island: a case study. Am J Public Health, 2001. 91(5): p. 699-700.

    63. Rich, J.D. and E. Jenny-Avital, Less than optimal? AIDS Clin Care, 2001. 13(7): p. 66-7, 70.

    64. Rich, J.D., et al., Risk factors for syphilis among incarcerated women in Rhode Island. AIDS Patient Care STDS, 2001. 15(11): p. 581-5.

    65. Rich, J.D., et al., Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health, 2001. 78(2): p. 279-89.

    66. Pugatch, D., et al., Heroin use in adolescents and young adults admitted for drug detoxification. J Subst Abuse, 2001. 13(3): p. 337-46.

    67. Mylonakis, E., M. Paliou, and J.D. Rich, Plasma viral load testing in the management of HIV infection. Am Fam Physician, 2001. 63(3): p. 483-90, 495-6.

    68. Mileno, M.D., et al., Factitious HIV syndrome in young women. AIDS Read, 2001. 11(5): p. 278-82.

    69. Clarke, J.G., et al., Active and Former Injection Drug Users Report of HIV Risk Behaviors During Periods of Incarceration. Subst Abus, 2001. 22(4): p. 209-216.

    70. Charuvastra, A., et al., Hepatitis B vaccination practices in state and federal prisons. Public Health Rep, 2001. 116(3): p. 203-9.

    71. Cannon, M.J., et al., Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med, 2001. 344(9): p. 637-43.

    72. Stein, M.D., et al., Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. Am J Drug Alcohol Abuse, 2000. 26(2): p. 195-205.

    73. Rich, J.D., et al., Strategies to optimize the impact of needle exchange programs. AIDS Read, 2000. 10(7): p. 421-9.

    74. Rich, J.D., et al., High street prices of syringes correlate with strict syringe possession laws. Am J Drug Alcohol Abuse, 2000. 26(3): p. 481-7.

    75. Mylonakis, E., et al., Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus. Arch Intern Med, 2000. 160(15): p. 2386-8.

    76. Farley, J.L., et al., Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience. J Womens Health Gend Based Med, 2000. 9(1): p. 51-6.

    77. Carpenter, C.C., et al., Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA, 2000. 283(3): p. 381-90.

    78. Burris, S., et al., Physician prescribing of sterile injection equipment to prevent HIV infection: time for action. Ann Intern Med, 2000. 133(3): p. 218-26.

    79. Willy, R.J., et al., Long-term non-progression of HIV-1 in a patient coinfected with HTLV-II. Diagn Microbiol Infect Dis, 1999. 35(4): p. 269-70.

    80. Vigilante, K.C., et al., Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning. J Womens Health, 1999. 8(3): p. 409-15.

    81. Spaulding, A.C., et al., Hepatitis B and C in the context of HIV disease: implications for incarcerated populations. AIDS Read, 1999. 9(7): p. 481-91.

    82. Rich, J.D., et al., Obstacles to needle exchange participation in Rhode Island. J Acquir Immune Defic Syndr, 1999. 21(5): p. 396-400.

    83. Rich, J.D., et al., Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C. Dig Dis Sci, 1999. 44(5): p. 1034-7.

    84. Rich, J.D., et al., Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med, 1999. 130(1): p. 37-9.

    85. Rich, J.D., et al., Needle exchange program participation by anabolic steroid injectors, United States 1998. Drug Alcohol Depend, 1999. 56(2): p. 157-60.

    86. Rich, J.D., et al., Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. J Acquir Immune Defic Syndr, 1999. 22(2): p. 161-6.

    87. Rich, J.D., et al., Local spread of molluscum contagiosum by electrolysis. Clin Infect Dis, 1999. 28(5): p. 1171.

    88. Rich, J.D., et al., Abscess related to anabolic-androgenic steroid injection. Med Sci Sports Exerc, 1999. 31(2): p. 207-9.

    89. Rich, J.D., et al., The infectious complications of anabolic-androgenic steroid injection. Int J Sports Med, 1999. 20(8): p. 563-6.

    90. Mylonakis, E., et al., Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis. Diagn Microbiol Infect Dis, 1999. 34(2): p. 111-4.

    91. Mylonakis, E., et al., Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy. Am J Hematol, 1999. 60(2): p. 164-6.

    92. Flanigan, T.P., J.D. Rich, and A. Spaulding, HIV care among incarcerated persons: a missed opportunity. AIDS, 1999. 13(17): p. 2475-6.

    93. Chodock, R., et al., Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment. Nephrol Dial Transplant, 1999. 14(10): p. 2484-6.

    94. Rich, J.D., L. Dokson, and B.P. Dickinson, The economic cost of strict syringe control. Med Health R I, 1998. 81(6): p. 207-8.

    95. Rich, J.D., et al., Interpretation of indeterminate HIV serology results in an incarcerated population. J Acquir Immune Defic Syndr Hum Retrovirol, 1998. 17(4): p. 376-9.

    96. Rich, J.D., et al., Insulin use by bodybuilders. JAMA, 1998. 279(20): p. 1613.

    97. Rich, J.D., et al., Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter. Am J Gastroenterol, 1998. 93(9): p. 1598.

    98. Rich, J.D., et al., Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol, 1998. 18 Suppl 1: p. S140-1.

    99. Rich, J.D., et al., Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS, 1998. 12(17): p. 2345-50.

    100. Pugatch, D., M. Mileno, and J.D. Rich, Possible transmission of human immunodeficiency virus type 1 from body piercing. Clin Infect Dis, 1998. 26(3): p. 767-8.

    101. Mylonakis, E., et al., Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA. AIDS, 1998. 12(8): p. 958-9.

    102. Mylonakis, E., et al., Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest, 1998. 114(1): p. 251-62.

    103. Dickinson, B.P., et al., Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care. AIDS, 1998. 12(15): p. 2075-6.

    104. Carpenter, C.C., et al., Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA, 1998. 280(1): p. 78-86.

    105. Rich, J.D., et al., Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons. Ann Allergy Asthma Immunol, 1997. 79(5): p. 409-14.

    106. Rich, J.D., B. Ramratnam, and T.P. Flanigan, Triple combination antiretroviral prophylaxis for needlestick exposure to HIV. Infect Control Hosp Epidemiol, 1997. 18(3): p. 161.

    107. Rich, J.D., et al., Management of indinavir associated nephrolithiasis. J Urol, 1997. 158(6): p. 2228.

    108. Rich, J.D., et al., HIV and syphilis prevalence in chittagong, Bangladesh. AIDS, 1997. 11(5): p. 703-4.

    109. Rich, J.D., et al., Hepatitis C and HIV in male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol, 1997. 16(5): p. 408-9.

    110. Pugatch, D., J.D. Rich, and T.P. Flanigan, HIV infection in Rhode Island adolescents. Med Health R I, 1997. 80(10): p. 331-3.

    111. Farrar, D.J., et al., Tuberculous brain abscess in a patient with HIV infection: case report and review. Am J Med, 1997. 102(3): p. 297-301.

    112. Carpenter, C.C., et al., Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA, 1997. 277(24): p. 1962-9.

    113. Lewis, D.C. and J.D. Rich, Physicians should support needle exchange in Rhode Island. Med Health R I, 1996. 79(6): p. 206.

    114. Flanigan, T.P., et al., Update of HIV and AIDS in North America. Med Health R I, 1996. 79(5): p. 180-7.

    115. Elliot, B.C., M. Rogers, and J.D. Rich, Indeterminate results of HIV testing: explanation and clinical management. Med Health R I, 1996. 79(10): p. 360-2.

    116. Cu-Uvin, S., et al., Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women. Am J Med, 1996. 101(3): p. 316-22.

    117. Carpenter, C.C., et al., Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA, 1996. 276(2): p. 146-54.

    118. Rich, J.D., P.E. Sax, and P.H. Kazanjian, Bacteremic H. influenzae type b infections and HIV. Am J Med, 1993. 95(1): p. 118-9.

    119. Rich, J.D., et al., Transmission of human immunodeficiency virus infection presumed to have occurred via female homosexual contact. Clin Infect Dis, 1993. 17(6): p. 1003-5.

    120. Rich, J.D., et al., Discrete gastrointestinal mass lesions caused by cytomegalovirus in patients with AIDS: report of three cases and review. Clin Infect Dis, 1992. 15(4): p. 609-14.